Profound Medical Corp. PROF
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 34.00% | 249.15% | 146.98% | 583.24% | -15.91% |
| Total Other Revenue | 3.27% | 37.37% | -14.36% | 53.26% | 6.92% |
| Total Revenue | 12.30% | 103.62% | 43.13% | 86.76% | -0.99% |
| Cost of Revenue | -9.61% | 95.96% | 63.59% | 30.08% | -26.97% |
| Gross Profit | 20.33% | 106.80% | 34.74% | 119.85% | 13.86% |
| SG&A Expenses | -21.09% | -19.73% | 6.46% | 12.18% | 84.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.41% | -3.11% | 6.59% | 20.05% | 58.98% |
| Operating Income | 19.85% | 28.17% | 11.70% | 0.94% | -76.05% |
| Income Before Tax | 39.32% | 34.21% | -57.16% | 14.50% | -126.54% |
| Income Tax Expenses | -14.06% | -39.02% | 110.92% | -31.64% | 236.84% |
| Earnings from Continuing Operations | 39.22% | 34.23% | -65.25% | 14.82% | -126.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.22% | 34.23% | -65.25% | 14.82% | -126.84% |
| EBIT | 19.85% | 28.17% | 11.70% | 0.94% | -76.05% |
| EBITDA | 20.01% | 28.01% | 10.45% | 0.20% | -79.61% |
| EPS Basic | 49.75% | 45.57% | -38.59% | 30.57% | -84.46% |
| Normalized Basic EPS | 49.83% | 45.57% | -31.90% | 30.33% | -84.30% |
| EPS Diluted | 49.75% | 45.57% | -38.59% | 30.57% | -84.46% |
| Normalized Diluted EPS | 49.83% | 45.57% | -31.90% | 30.33% | -84.30% |
| Average Basic Shares Outstanding | 20.95% | 20.82% | 19.23% | 22.70% | 22.96% |
| Average Diluted Shares Outstanding | 20.95% | 20.82% | 19.23% | 22.70% | 22.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |